Nationwide Recall Issued for Atorvastatin Calcium Tablets Due to Dissolution Issues
A significant nationwide recall has been initiated for Atorvastatin Calcium tablets, a commonly prescribed statin medication. This action by the U.S. Food and Drug Administration (FDA) impacts over 141,984 bottles of the drug, which are used to manage high cholesterol. The primary reason for this recall is identified as \"failed dissolution specifications,\" meaning the tablets may not dissolve properly in the body, potentially affecting their efficacy. This presents a concern for individuals relying on these medications to control their cholesterol levels.
The affected Atorvastatin Calcium tablets are available in various dosages, specifically 10 mg, 20 mg, 40 mg, and 80 mg, and are sold in 90-count, 500-count, and 1000-count packages. Consumers are urged to carefully inspect their current medication for specific lot numbers and expiration dates that fall within the recall parameters. These details can be found on the bottles or packaging of the medication. The recall has been classified as a Class II recall, indicating that the use of these products may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote.
The U.S. Food and Drug Administration (FDA) has identified multiple lot numbers and expiration dates for the Atorvastatin Calcium tablets that are subject to this recall. For the 10 mg dosage, lot numbers include 25141249, 24144938, 24144868, 24144867, 24144458, 24143994, 24142987, and 24143316, with expiration dates ranging from February 2027 to July 2026. For the 40 mg dosage, affected lot numbers are 25140933, 25140477, 24144254, 24144163, and 24143995, with expiration dates between February 2027 and September 2026. The 20 mg dosage includes lot numbers such as 25140150, 25140173, 25140172, 24144720, 24144798, 24144692, 24143755, 24143913, 24143754, 24143047, and 24142936, with expiration dates from December 2026 to June 2026. Lastly, the 80 mg dosage has lot numbers 25140249, 25140247, 24144999, 24144942, 24144845, 24144713, 24144652, 24143898, 24143412, and 24143582, expiring between December 2026 and August 2026. It is imperative that individuals verify these details against their personal prescriptions.
Patients who find their Atorvastatin Calcium tablets match the recalled information should immediately contact their healthcare provider or pharmacy. They can arrange for a replacement medication or inquire about a potential refund for the affected product. This proactive measure is crucial to ensure uninterrupted and effective cholesterol management. The FDA has made it clear that while this is a Class II recall, suggesting minor or temporary health issues, it is always best to err on the side of caution and replace any compromised medication.
In light of this widespread recall, the FDA advises all consumers using Atorvastatin Calcium tablets to review their prescription bottles and packaging meticulously. The comprehensive list of affected lot numbers and expiration dates across various strengths of the medication is readily available. Should a match be identified, promptly contacting a medical professional or dispensing pharmacy is the recommended course of action. This ensures the prompt replacement of potentially ineffective medication and helps maintain the continuity of treatment for high cholesterol.
